Molecular detection and assessment of the epidemiological risk factors associated with equine herpesvirus 2 and 5 in working equids in central Ethiopia.
EHV-2
EHV-5
Ethiopia
PCR
equids
respiratory disease
Journal
Veterinary medicine and science
ISSN: 2053-1095
Titre abrégé: Vet Med Sci
Pays: England
ID NLM: 101678837
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
pubmed:
6
9
2022
medline:
23
11
2022
entrez:
5
9
2022
Statut:
ppublish
Résumé
Respiratory disease is the most common presenting complaint at veterinary clinics and a priority concern for equid owners and veterinary practitioners in Ethiopia. This study aimed to report the molecular detection of EHV-2 and EHV-5 and to assess the risk factors associated with infection in working equids in central Ethiopia. Nasopharyngeal swabs were collected from 58 horses and donkeys to detect EHV-2 and EHV-5 using PCR targeting the conserved region of glycoprotein B (gB) genes. From 58 equids, EHV-5 and EHV-2 were detected in 20 (34.5%) and 19 (32.8%) equids, respectively. Concurrent infection with EHV-2 and EHV-5 was found in 6 (10.3%) equids who exhibited respiratory clinical signs. EHV-2 was detected in a significantly higher (p = 0.002) proportion of horses (54.5%; n = 18) than donkeys (4%; n = 1). In contrast, EHV-5 was detected in a significantly higher (p = 0.004) proportion of donkeys (56%; n = 14) compared to horses (18.2% n = 6). EHV-2-positive equids were seven times more likely to display clinical signs of respiratory disease than EHV-2-negative equids (Odds ratio (OR) = 6.9; 95%CI: 1.72-27.60). However, statistically significant (p = 0.832) difference was not observed for EHV-5. EHV-2 was detected in a significantly higher (p = 0.004) proportion of female (50%; n = 16) compared to male equids (11.5%; n = 3). This study revealed the molecular detection of EHV-2 and EHV-5 in horses and donkeys residing in central Ethiopia. The association between EHV-2-test-positive equids and displaying of clinical signs of respiratory disease was observed, which suggests EHV-2 involvement in the development of respiratory disease; however, it deserves further investigation.
Sections du résumé
BACKGROUND
Respiratory disease is the most common presenting complaint at veterinary clinics and a priority concern for equid owners and veterinary practitioners in Ethiopia.
OBJECTIVES
This study aimed to report the molecular detection of EHV-2 and EHV-5 and to assess the risk factors associated with infection in working equids in central Ethiopia.
METHODS
Nasopharyngeal swabs were collected from 58 horses and donkeys to detect EHV-2 and EHV-5 using PCR targeting the conserved region of glycoprotein B (gB) genes.
RESULTS
From 58 equids, EHV-5 and EHV-2 were detected in 20 (34.5%) and 19 (32.8%) equids, respectively. Concurrent infection with EHV-2 and EHV-5 was found in 6 (10.3%) equids who exhibited respiratory clinical signs. EHV-2 was detected in a significantly higher (p = 0.002) proportion of horses (54.5%; n = 18) than donkeys (4%; n = 1). In contrast, EHV-5 was detected in a significantly higher (p = 0.004) proportion of donkeys (56%; n = 14) compared to horses (18.2% n = 6). EHV-2-positive equids were seven times more likely to display clinical signs of respiratory disease than EHV-2-negative equids (Odds ratio (OR) = 6.9; 95%CI: 1.72-27.60). However, statistically significant (p = 0.832) difference was not observed for EHV-5. EHV-2 was detected in a significantly higher (p = 0.004) proportion of female (50%; n = 16) compared to male equids (11.5%; n = 3).
CONCLUSIONS
This study revealed the molecular detection of EHV-2 and EHV-5 in horses and donkeys residing in central Ethiopia. The association between EHV-2-test-positive equids and displaying of clinical signs of respiratory disease was observed, which suggests EHV-2 involvement in the development of respiratory disease; however, it deserves further investigation.
Identifiants
pubmed: 36063540
doi: 10.1002/vms3.925
pmc: PMC9677389
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2396-2403Informations de copyright
© 2022 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd.
Références
Vet Microbiol. 2017 Aug;207:205-209
pubmed: 28757025
Virol J. 2018 Jul 11;15(1):106
pubmed: 29996858
Vet Microbiol. 2013 Nov 29;167(1-2):123-34
pubmed: 23890672
Vet Med Sci. 2019 Aug;5(3):361-371
pubmed: 31149784
Vet Microbiol. 1996 Jul;51(1-2):55-68
pubmed: 8828122
Vet Clin North Am Equine Pract. 2015 Apr;31(1):91-104
pubmed: 25648568
Equine Vet J. 2018 Nov;50(6):793-799
pubmed: 29574904
Vet Microbiol. 2006 Sep 10;116(4):249-57
pubmed: 16774810
Transbound Emerg Dis. 2010 Aug 1;57(4):271-6
pubmed: 20553426
N Z Vet J. 2014 Jul;62(4):226-31
pubmed: 24597743
Res Vet Sci. 2008 Dec;85(3):605-11
pubmed: 18336849
Arch Virol. 1999;144(2):287-307
pubmed: 10470254
Vet Res. 2002 May-Jun;33(3):251-9
pubmed: 12056476
Vet J. 2010 Nov;186(2):148-56
pubmed: 19766026
Arch Virol. 2009;154(1):171-7
pubmed: 19066710
Vet Res. 2019 Feb 18;50(1):13
pubmed: 30777128
Front Vet Sci. 2018 Sep 25;5:224
pubmed: 30320126
Vet Microbiol. 2013 Nov 29;167(1-2):86-92
pubmed: 23845734
Vet Microbiol. 2013 May 31;164(1-2):139-44
pubmed: 23434188
Vet Microbiol. 2007 Mar 31;121(1-2):18-28
pubmed: 17208393
Transbound Emerg Dis. 2017 Apr;64(2):389-397
pubmed: 26010868
Prev Vet Med. 2005 Jul 12;69(3-4):265-83
pubmed: 15907574
N Z Vet J. 2002 Aug;50(4):140-7
pubmed: 16032260
Transbound Emerg Dis. 2017 Dec;64(6):1970-1978
pubmed: 28102009
Vet Med Sci. 2022 Nov;8(6):2396-2403
pubmed: 36063540
Arch Virol. 2008;153(9):1643-9
pubmed: 18677574
Vet Pathol. 2007 Nov;44(6):849-62
pubmed: 18039898